TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.2, ss.127-130, 2016 (SCI-Expanded)
Objective: The aim of this study was to investigate the effects of imatinib mesylate on platelet aggregation and adenosine triphosphate (ATP) release in chronic myeloid leukemia patients.